LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

Search

Globus Medical Inc (Class A)

Ouvert

SecteurSoins de santé

91.79 1.32

Résumé

Variation du prix de l'action

24h

Actuel

Min

90.36

Max

91.75

Chiffres clés

By Trading Economics

Revenu

-84M

119M

Ventes

24M

769M

P/E

Moyenne du Secteur

28.508

110.024

BPA

1.18

Marge bénéficiaire

15.469

Employés

5,300

EBITDA

22M

215M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+17.56% upside

Dividendes

By Dow Jones

Prochains Résultats

24 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

3.6B

12B

Ouverture précédente

90.47

Clôture précédente

91.79

Sentiment de l'Actualité

By Acuity

78%

22%

324 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Globus Medical Inc (Class A) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 févr. 2026, 23:55 UTC

Market Talk

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

22 févr. 2026, 23:53 UTC

Market Talk

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

22 févr. 2026, 23:53 UTC

Market Talk

Key China Rates Likely to Be Held Steady for Now -- Market Talk

22 févr. 2026, 23:51 UTC

Market Talk

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

22 févr. 2026, 23:35 UTC

Market Talk

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

22 févr. 2026, 23:21 UTC

Résultats

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

22 févr. 2026, 23:20 UTC

Résultats

Nickel Industries 2025 Operating Profit US$126.4 Million

22 févr. 2026, 23:19 UTC

Résultats

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

22 févr. 2026, 23:19 UTC

Résultats

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

22 févr. 2026, 23:18 UTC

Résultats

Nickel Industries Won't Pay a Final Dividend

22 févr. 2026, 23:16 UTC

Résultats

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

22 févr. 2026, 21:35 UTC

Résultats

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

22 févr. 2026, 21:34 UTC

Résultats

Ampol Says F&I Australia, International Have Begun 2026 Strongly

22 févr. 2026, 21:34 UTC

Résultats

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

22 févr. 2026, 21:33 UTC

Résultats

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

22 févr. 2026, 21:33 UTC

Résultats

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

22 févr. 2026, 21:28 UTC

Résultats

Ampol Final Dividend A$0.60/Share

22 févr. 2026, 21:28 UTC

Résultats

Ampol FY Revenue A$31.37 Billion, Down 10%

22 févr. 2026, 21:28 UTC

Résultats

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

22 févr. 2026, 21:28 UTC

Résultats

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

21 févr. 2026, 14:31 UTC

Acquisitions, Fusions, Rachats

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21 févr. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

20 févr. 2026, 23:12 UTC

Acquisitions, Fusions, Rachats

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 févr. 2026, 22:12 UTC

Résultats

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20 févr. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20 févr. 2026, 21:23 UTC

Résultats

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 févr. 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 févr. 2026, 21:01 UTC

Acquisitions, Fusions, Rachats

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 févr. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Comparaison

Variation de prix

Globus Medical Inc (Class A) prévision

Objectif de Prix

By TipRanks

17.56% hausse

Prévisions sur 12 Mois

Moyen 106.5 USD  17.56%

Haut 118 USD

Bas 87 USD

Basé sur 14 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

14 ratings

11

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

72.18 / 73.07Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

324 / 351Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat